Collegium Pharmaceutical Inc (COLL)
Quick ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 238,947 | 173,688 | 186,426 | 174,116 | 170,019 |
| Short-term investments | US$ in thousands | 147,931 | 0 | — | — | — |
| Receivables | US$ in thousands | 179,525 | 183,119 | 105,844 | 83,320 | 72,953 |
| Total current liabilities | US$ in thousands | 457,915 | 433,726 | 279,566 | 239,451 | 201,765 |
| Quick ratio | 1.24 | 0.82 | 1.05 | 1.08 | 1.20 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($238,947K
+ $147,931K
+ $179,525K)
÷ $457,915K
= 1.24
The quick ratio of Collegium Pharmaceutical Inc has varied over the past five years. The ratio indicates the company's ability to meet its short-term obligations using its most liquid assets. In 2023, the quick ratio improved to 1.10 from 0.86 in 2022, suggesting an enhancement in the company's short-term liquidity position. However, it is still slightly below the 2019 level of 1.22. The ratios for 2021 and 2020 were 1.07 and 1.10, respectively, indicating a relatively stable liquidity position during those years. Overall, while the recent improvement in the quick ratio is positive, further monitoring of liquidity management is prudent to ensure the company's ability to meet short-term obligations effectively.
Peer comparison
Dec 31, 2023